MedPath

Comparing Carbetocin and Oxytocin for preventing bleeding in Postpartum wome

Phase 4
Conditions
Health Condition 1: - Health Condition 2: O721- Other immediate postpartum hemorrhage
Registration Number
CTRI/2024/07/071389
Lead Sponsor
Department of Obstetrics and Gynaecology AIIMS Bathinda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Pregnant women at 34 to 40 weeks of gestation undergoing vaginal delivery or cesarean section giving consent to participate

Exclusion Criteria

1.Known case of hypersensitivity to oxytocin and carbetocin13

2.Women with coagulation defects

3.Women with medical conditions (pulmonary, hepatic, renal or cardiovascular disease)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath